http://orcid.org/0000-0002-3397-7331
Citations (57)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Serena Marchi, Elettra Fallani, Marco Salvatore, Emanuele Montomoli & Claudia Maria Trombetta. (2023) The burden of influenza and the role of influenza vaccination in adults aged 50-64 years: A summary of available evidence. Human Vaccines & Immunotherapeutics 19:2.
Read now
Read now
Laura Nuzzolo-Shihadeh, Elvira Garza-Gonzalez, Samantha Flores-Treviño, Raul Salazar-Montalvo & Adrian Camacho-Ortiz. (2022) Hospitalization and risk of death due to influenza among vaccinated and unvaccinated patients. A 5-year study in the northeastern Mexican population. Human Vaccines & Immunotherapeutics 18:7.
Read now
Read now
George N. Okoli, Viraj K. Reddy, Otto L. T. Lam, Florentin Racovitan, Yahya Al-Yousif & Nicole Askin. (2022) Characteristics and methodological standards across systematic reviews with Meta-analysis of efficacy and/or effectiveness of influenza vaccines: an overview of reviews. Infectious Diseases 54:12, pages 861-880.
Read now
Read now
Jesús Ruiz-Aragón, Ray Gani, Sergio Márquez & Piedad Alvarez. (2021) Reply to letter from Alvarez et al.. Human Vaccines & Immunotherapeutics 17:3, pages 696-697.
Read now
Read now
Salvatore Zaffina, Francesco Gilardi, Caterina Rizzo, Serena Sannino, Rita Brugaletta, Annapaola Santoro, Guido Castelli Gattinara, Marta Luisa Ciofi degli Atti, Massimiliano Raponi & Maria Rosaria Vinci. (2019) Seasonal influenza vaccination and absenteeism in health-care workers in two subsequent influenza seasons (2016/17 and 2017/18) in an Italian pediatric hospital. Expert Review of Vaccines 18:4, pages 411-418.
Read now
Read now
Yung-wai Desmond Chan, Miu-ling Wong, Ka-wing Au & Shuk-kwan Chuang. (2019) Seasonal influenza vaccine effectiveness at primary care level, Hong Kong SAR, 2017/2018 winter. Human Vaccines & Immunotherapeutics 15:1, pages 97-101.
Read now
Read now
Susanna Esposito & Nicola Principi. (2018) Influenza vaccination and prevention of antimicrobial resistance. Expert Review of Vaccines 17:10, pages 881-888.
Read now
Read now
Susanna Esposito. (2018) 100 years since the 1918 influenza pandemic. Human Vaccines & Immunotherapeutics 14:3, pages 504-507.
Read now
Read now
Guglielmo Dini, Alessandra Toletone, Laura Sticchi, Andrea Orsi, Nicola Luigi Bragazzi & Paolo Durando. (2018) Influenza vaccination in healthcare workers: A comprehensive critical appraisal of the literature. Human Vaccines & Immunotherapeutics 14:3, pages 772-789.
Read now
Read now
Articles from other publishers (48)
Lauren A. Chang, Angela Choi, Raveen Rathnasinghe, Prajakta Warang, Moataz Noureddine, Sonia Jangra, Yong Chen, Bruno G. De Geest & Michael Schotsaert. (2023) Influenza breakthrough infection in vaccinated mice is characterized by non-pathological lung eosinophilia. Frontiers in Immunology 14.
Crossref
Crossref
Ibrahim Alharbi, Reem Alharthi, Shuaa Aljabri, Razan Alzhrani, Lujain Alzahrani & Saad Albagami. (2023) Seasonal Influenza Vaccination Among Saudi Children: Parental Barriers and Willingness to Vaccinate Their Children in the Makkah Region. Cureus.
Crossref
Crossref
Iván Sanz-Muñoz, Conrado Lajara, José Ignacio Echarrén, Asunción Caminero-Pérez, Luis Teso-Fernández & José María Eiros. (2023) Active medical recommendation is the best tool for increasing influenza vaccine coverage in healthy adult workers. Vacunas (English Edition) 24:2, pages 88-94.
Crossref
Crossref
Iván Sanz-Muñoz, Conrado Lajara, José Ignacio Echarrén, Asunción Caminero-Pérez, Luis Teso-Fernández & José María Eiros. (2023) Active medical recommendation is the best tool for increasing influenza vaccine coverage in healthy adult workers. Vacunas 24:2, pages 88-94.
Crossref
Crossref
Iván Sanz-Muñoz, Rosa López-Mongil, Javier Sánchez-Martínez, Laura Sánchez-de Prada, Marta Domínguez-Gil González, Diana Pérez-SanJose, Silvia Rojo-Rello, Cristina Hernán-García, Virginia Fernández-Espinilla, Raúl Ortiz de Lejarazu-Leonardo, Javier Castrodeza-Sanz & José María Eiros. (2023) Evolution of antibody profiles against SARS-CoV-2 in experienced and naïve vaccinated elderly people. Frontiers in Immunology 14.
Crossref
Crossref
Xinyun Zhang, Ying Yang, ShengSen Chen, Wenchao Li, Yong Li, Brian J. Akerley, Linyun Shao, Wenhong Zhang, Hao Shen & Michael C. Abt. (2023) Antigen-specific memory Th17 cells promote cross-protection against nontypeable Haemophilus influenzae after mild influenza A virus infection. Mucosal Immunology.
Crossref
Crossref
Dalal Youssef, Atika Berry, Janet Youssef & Linda Abou-Abbas. (2022) Vaccination against influenza among Lebanese health care workers in the era of coronavirus disease 2019. BMC Public Health 22:1.
Crossref
Crossref
Katie Gravagna, Christina Wolfson, Giorgia Sulis, Sarah A. Buchan, Shelly McNeil, Melissa K. Andrew, Jacqueline McMillan, Susan Kirkland & Nicole E. Basta. (2022) Influenza vaccine coverage and factors associated with non-vaccination among adults at high risk for severe outcomes: An analysis of the Canadian Longitudinal Study on Aging. PLOS ONE 17:9, pages e0275135.
Crossref
Crossref
Shan Jin, Chenyan Jiang, Tian Xia, Zhen Gu, Huiting Yu, Jing Li, Yaxu Zheng, Hao Pan, Jiaying Qiao, Renzhi Cai, Huanyu Wu & Chunfang Wang. (2022) Age-dependent and sex-dependent differences in mortality from influenza-associated cardiovascular diseases among older adults in Shanghai, China: a population-based study. BMJ Open 12:9, pages e061068.
Crossref
Crossref
Yuanjie Pang, Xiaofan Liu, Guangqi Liu, Min Lv, Ming Lu, Jiang Wu & Yangmu Huang. (2022) Effectiveness of influenza vaccination on in-hospital death and recurrent hospitalization in older adults with cardiovascular diseases. International Journal of Infectious Diseases 122, pages 162-168.
Crossref
Crossref
S. N. Avdeev, A. V. Dekhnich, A. A. Zaytsev, R. S. Kozlov, S. A. Rachina, V. A. Rudnov, A. I. Sinopal’nikov, I. E. Tyurin, O. V. Fesenko & A. G. Chuchalin. (2022) Federal guidelines on diagnosis and treatment of community-acquired pneumonia. PULMONOLOGIYA 32:3, pages 295-355.
Crossref
Crossref
Christopher Gupta, Anjali Sachdeva, Jigish Khamar, Cecilia Bu, Jessica Bartoszko & Mark Loeb. (2022) Effectiveness of the influenza vaccine at reducing adverse events in patients with heart failure: A systematic review and meta-analysis. Vaccine 40:25, pages 3433-3443.
Crossref
Crossref
Gerald Voss, Jeanne-Marie Jacquet, Nadia Tornieporth, Beate Kampmann, Ruth Karron, Ajoke Sobanjo-ter Meulen, Robert Chen, Marion Gruber, Nicole Lurie, Charlie Weller, Jakob P. Cramer, Melanie Saville & Mimi Darko. (2021) Meeting report: CEPI consultation on accelerating access to novel vaccines against emerging infectious diseases for pregnant and lactating women, London, 12–13 February 2020. Vaccine 39:51, pages 7357-7362.
Crossref
Crossref
Ariel Jordan, Krystal Mills, Timothy Sobukonla, Alexander Kelly & Michael Flood. (2021) Influenza, PCV13, and PPSV23 Vaccination Rates Among Inflammatory Bowel Disease Patients With Additional Co-Morbidities as per CDC Recommendations. Cureus.
Crossref
Crossref
Wiebke Kathrin Kohl-Heckl, Marleen Schröter, Gustav Dobos & Holger Cramer. (2021) Complementary medicine use and flu vaccination – A nationally representative survey of US adults. Vaccine 39:39, pages 5635-5640.
Crossref
Crossref
Marco Dettori, Antonella Arghittu, Giovanna Deiana, Antonio Azara, Maria Dolores Masia, Alessandra Palmieri, Antonio Lorenzo Spano, Antonello Serra & Paolo Castiglia. (2021) Influenza Vaccination Strategies in Healthcare Workers: A Cohort Study (2018–2021) in an Italian University Hospital. Vaccines 9:9, pages 971.
Crossref
Crossref
Constantina Boikos, Mahrukh Imran, Van Hung Nguyen, Thierry Ducruet, Gregg C. Sylvester & James A. Mansi. (2021) Effectiveness of the Adjuvanted Influenza Vaccine in Older Adults at High Risk of Influenza Complications. Vaccines 9:8, pages 862.
Crossref
Crossref
Constantina Boikos, Mahrukh Imran, Van Hung Nguyen, Thierry Ducruet, Gregg C Sylvester & James A Mansi. (2021) Effectiveness of the Cell-Derived Inactivated Quadrivalent Influenza Vaccine in Individuals at High Risk of Influenza Complications in the 2018–2019 United States Influenza Season. Open Forum Infectious Diseases 8:7.
Crossref
Crossref
Saverio Caini, John Paget, Peter Spreeuwenberg, Joke C. Korevaar, Adam Meijer & Mariëtte Hooiveld. (2021) Impact of influenza vaccination in the Netherlands, 2007–2016: Vaccinees consult their general practitioner for clinically diagnosed influenza, acute respiratory infections, and pneumonia more often than non-vaccinees. PLOS ONE 16:5, pages e0249883.
Crossref
Crossref
Ruitong Wang, Min Liu & Jue Liu. (2021) The Association between Influenza Vaccination and COVID-19 and Its Outcomes: A Systematic Review and Meta-Analysis of Observational Studies. Vaccines 9:5, pages 529.
Crossref
Crossref
Antoni Torres, Catia Cilloniz, Michael S. Niederman, Rosario Menéndez, James D. Chalmers, Richard G. Wunderink & Tom van der Poll. (2021) Pneumonia. Nature Reviews Disease Primers 7:1.
Crossref
Crossref
Kiyosu Taniguchi, Shunya Ikeda, Yuriko Hagiwara, Daisuke Tsuzuki, Marwa Klai, Yoko Sakai, Bruce Crawford & Joshua Nealon. (2020) Epidemiology and burden of illness of seasonal influenza among the elderly in Japan: A systematic literature review and vaccine effectiveness meta‐analysis. Influenza and Other Respiratory Viruses 15:2, pages 293-314.
Crossref
Crossref
Jiyoung You & Jinhyang Yang. (2021) Factors Influencing Influenza Vaccination Intention among Health Personnel in General Hospitals: An Application of the Theory of Planned Behavior. Journal of Korean Academy of Community Health Nursing 32:2, pages 175.
Crossref
Crossref
Rosalind Hollingsworth, Clotilde El Guerche‐Séblain, Theodore Tsai, Yuri Vasiliev, Sam Lee, Helen Bright & Paula Barbosa. (2020) Assessment of the benefits of seasonal influenza vaccination: Elements of a framework to interpret estimates of vaccine effectiveness and support robust decision‐making and communication. Influenza and Other Respiratory Viruses 15:1, pages 164-174.
Crossref
Crossref
Michael S. KramerMichael S. Kramer. 2021. Beyond Parenting Advice. Beyond Parenting Advice
91
96
.
Sankarasubramanian Rajaram, Pirada Suphaphiphat, Josephine van Boxmeer, Mendel Haag, Brett Leav, Ike Iheanacho, Kristin Kistler & Raúl Ortiz de Lejarazu. (2020) Retrospective Assessment of the Antigenic Similarity of Egg-Propagated and Cell Culture-Propagated Reference Influenza Viruses as Compared with Circulating Viruses across Influenza Seasons 2002–2003 to 2017–2018. International Journal of Environmental Research and Public Health 17:15, pages 5423.
Crossref
Crossref
Fumi Sato-Kaneko, Shiyin Yao, Fitzgerald S. Lao, Jonathan Shpigelman, Karen Messer, Minya Pu, Nikunj M. Shukla, Howard B. Cottam, Michael Chan, Paul J. Chu, David Burkhart, Roman Schoener, Takaji Matsutani, Dennis A. Carson, Maripat Corr & Tomoko Hayashi. (2020) A Novel Synthetic Dual Agonistic Liposomal TLR4/7 Adjuvant Promotes Broad Immune Responses in an Influenza Vaccine With Minimal Reactogenicity. Frontiers in Immunology 11.
Crossref
Crossref
Manuel Maffeo, Ester Luconi, Ambra Castrofino, Emanuela Maria Campagnoli, Andrea Cinnirella, Federica Fornaro, Claudia Gallana, Pier Mario Perrone, Viktoriia Shishmintseva, Elena Pariani & Silvana Castaldi. (2020) 2019 Influenza Vaccination Campaign in an Italian Research and Teaching Hospital: Analysis of the Reasons for Its Failure. International Journal of Environmental Research and Public Health 17:11, pages 3881.
Crossref
Crossref
Joanne Marie M. Del Rosario, Matthew Smith, Kam Zaki, Paul Risley, Nigel Temperton, Othmar G. Engelhardt, Mary Collins, Yasuhiro Takeuchi & Simon E. Hufton. (2020) Protection From Influenza by Intramuscular Gene Vector Delivery of a Broadly Neutralizing Nanobody Does Not Depend on Antibody Dependent Cellular Cytotoxicity. Frontiers in Immunology 11.
Crossref
Crossref
Marc Mendelson. (2020) Could enhanced influenza and pneumococcal vaccination programs help limit the potential damage from SARS-CoV-2 to fragile health systems of southern hemisphere countries this winter?. International Journal of Infectious Diseases 94, pages 32-33.
Crossref
Crossref
Steffie K. Naber, Patricia C.J.L. Bruijning-Verhagen, Marieke L.A. de Hoog & Anoukh van Giessen. (2020) Cost-effectiveness of inactivated influenza vaccination in children with medical risk conditions in the Netherlands. Vaccine 38:17, pages 3387-3396.
Crossref
Crossref
Elisa Lai, Hao Yi Tan, Mohana Kunasekaran, Abrar Ahmad Chughtai, Mallory Trent, Christopher Poulos & C. Raina MacIntyre. (2020) Influenza vaccine coverage and predictors of vaccination among aged care workers in Sydney Australia. Vaccine 38:8, pages 1968-1974.
Crossref
Crossref
Raja Dhar, AlokeGopal Ghoshal, Randeep Guleria, Shubham Sharma, Tarang Kulkarni, Rajesh Swarnakar, JK Samaria, Sudhir Chaudhary, SN Gaur, DJ Christopher, Virendra Singh, Georgi Abraham, Anirban Sarkar, Ansuman Mukhopadhyay, Jayant Panda, Subramanian Swaminathan, Amita Nene, Shyam Krishnan, PraveenKumar Shahi, Nikhil Sarangdhar, Narayan Mishra, SusmitaRoy Chowdury, Indranil Halder, SK Katiyar, VK Jain, Rakesh Chawla & ParvaizA Koul. (2020) Clinical practice guidelines 2019: Indian consensus-based recommendations on influenza vaccination in adults. Lung India 37:7, pages 4.
Crossref
Crossref
Elias Ronca, Melissa Miller & Martin W. G. Brinkhof. (2019) Poor adherence to influenza vaccination guidelines in spinal cord injury: results from a community-based survey in Switzerland. Spinal Cord 58:1, pages 18-24.
Crossref
Crossref
Peter Johannes Schulz, Yi-Chen Wu, Soontae An & Fu-Li Chen. (2019) Social Influences on Influenza Vaccination Decision Among Senior Citizens in Taiwan, South Korea, and Switzerland. Frontiers in Communication 4.
Crossref
Crossref
Fabio Tramuto, Vincenzo RestivoClaudio CostantinoGiuseppina Maria Elena Colomba, Carmelo Massimo MaidaAlessandra CasuccioFrancesco Vitale. (2019) Surveillance Data for Eight Consecutive Influenza Seasons in Sicily, Italy. The American Journal of Tropical Medicine and Hygiene 101:6, pages 1232-1239.
Crossref
Crossref
Luciano Pinto, Raffaele Falsaperla, Alberto Villani, Giovanni Corsello, Roberto Del Gado, Adolfo Mazzeo & Riccardo Lubrano. (2019) Influenza vaccination: opinions of health care professionals working in pediatric emergency departments. Italian Journal of Pediatrics 45:1.
Crossref
Crossref
Steffie K. Naber, Patricia C.J.L. Bruijning-Verhagen, Marieke L.A. de Hoog & Anoukh van Giessen. (2019) WITHDRAWN: Cost-effectiveness of inactivated influenza vaccination in children with medical risk conditions in the Netherlands. Vaccine: X, pages 100053.
Crossref
Crossref
Claudio Costantino & Francesco Vitale. (2019) The relevance for Public Health of the mid-term and interim analyses of seasonal influenza vaccination effectiveness. Future Virology 14:10, pages 629-632.
Crossref
Crossref
Linda Sanftenberg, Felix Brombacher, Jörg Schelling, Stefanie J. Klug & Jochen Gensichen. (2019) Increasing Influenza Vaccination Rates in People With Chronic Illness. Deutsches Ärzteblatt international.
Crossref
Crossref
Allen C Cheng, Mark Holmes, Dominic E Dwyer, Sanjaya Senenayake, Louise Cooley, Louis Irving, Graham Simpson, Tony Korman, Kristine Macartney, N Deborah Friedman, Peter Wark, Anna Holwell, Christopher Blyth, Simon Bowler, John Upton, Grant Waterer, Tom Kotsimbos & Paul Kelly. (2019) Influenza epidemiology in patients admitted to sentinel Australian hospitals in 2017: the Influenza Complications Alert Network (FluCAN). Communicable Diseases Intelligence 43.
Crossref
Crossref
Claudio Costantino, Vincenzo Restivo, Emanuele Amodio, Giuseppina Maria Elena Colomba, Francesco Vitale & Fabio Tramuto. (2019) A mid-term estimate of 2018/2019 vaccine effectiveness to prevent laboratory confirmed A(H1N1)pdm09 and A(H3N2) influenza cases in Sicily (Italy). Vaccine 37:39, pages 5812-5816.
Crossref
Crossref
Dawn C. Jenkin, Hamid Mahgoub, Kathleen F. Morales, Philipp Lambach & Jonathan S. Nguyen-Van-Tam. (2019) A rapid evidence appraisal of influenza vaccination in health workers: An important policy in an area of imperfect evidence. Vaccine: X 2, pages 100036.
Crossref
Crossref
Claudio Costantino, Vincenzo Restivo, Fabio Tramuto, Alessandra Casuccio & Francesco Vitale. (2019) Influenza vaccination of healthcare workers in Italy: could mandatory vaccination be a solution to protect patients?. Future Microbiology 14:9s, pages 45-49.
Crossref
Crossref
Andrés Pizzorno, Blandine Padey, Olivier Terrier & Manuel Rosa-Calatrava. (2019) Drug Repurposing Approaches for the Treatment of Influenza Viral Infection: Reviving Old Drugs to Fight Against a Long-Lived Enemy. Frontiers in Immunology 10.
Crossref
Crossref
Kriengkrai Prasert, Jayanton Patumanond, Prabda Praphasiri, Supakit Siriluk, Darunee Ditsungnoen, Malinee Chittaganpich, Fatimah S. Dawood, Joshua A. Mott & Kim A. Lindblade. (2019) Effectiveness of trivalent inactivated influenza vaccine among community-dwelling older adults in Thailand: A two-year prospective cohort study. Vaccine 37:6, pages 783-791.
Crossref
Crossref
Evan Ackermann. (2018) The Case Against. Journal of Pharmacy Practice and Research 48:3, pages 277-280.
Crossref
Crossref
Francesco Gilardi, Guido Castelli Gattinara, Maria Vinci, Marta Ciofi Degli Atti, Veronica Santilli, Rita Brugaletta, Annapaola Santoro, Rosina Montanaro, Luisa Lavorato, Massimiliano Raponi & Salvatore Zaffina. (2018) Seasonal Influenza Vaccination in Health Care Workers. A Pre-Post Intervention Study in an Italian Paediatric Hospital. International Journal of Environmental Research and Public Health 15:5, pages 841.
Crossref
Crossref